[go: up one dir, main page]

陳露, 2022 - Google Patents

Study on the role of neuropeptide receptor VPAC2

陳露, 2022

View PDF
Document ID
5831803051533753699
Author
陳露
Publication year

External Links

Snippet

Schizophrenia is a chronic disabling brain disorder affecting approximately 1% of the world's population, and nearly 10% of those with schizophrenia have an affected first-degree relative. Schizophrenia is mainly characterized by positive symptoms such as hallucinations …
Continue reading at ir.library.osaka-u.ac.jp (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Huang et al. A robust TDP-43 knock-in mouse model of ALS
Tian et al. The role of Snapin in neurosecretion: snapin knock-out mice exhibit impaired calcium-dependent exocytosis of large dense-core vesicles in chromaffin cells
Chiu et al. GRASP1 regulates synaptic plasticity and learning through endosomal recycling of AMPA receptors
Zhang et al. Intraflagellar transporter protein 140 (IFT140), a component of IFT‐A complex, is essential for male fertility and spermiogenesis in mice
Castroflorio et al. The Ncoa7 locus regulates V-ATPase formation and function, neurodevelopment and behaviour
Bruyere et al. Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin
Yang et al. Brain‐Specific SNAP‐25 Deletion Leads to Elevated Extracellular Glutamate Level and Schizophrenia‐Like Behavior in Mice
Matsuura et al. SIPA1L1/SPAR1 interacts with the neurabin family of proteins and is involved in GPCR signaling
Hilal et al. Activity-dependent neuroplasticity induced by an enriched environment reverses cognitive deficits in scribble deficient mouse
Garcia‐Agudo et al. BIN1K358R suppresses glial response to plaques in mouse model of Alzheimer's disease
Fernández-Suárez et al. Adult medial habenula neurons require GDNF receptor GFRα1 for synaptic stability and function
US12116611B2 (en) Method of treating intellectual disability, autism and epilepsy associated with an IQSEC2 mutation and for identifying medicaments for treating the same
陳露 Study on the role of neuropeptide receptor VPAC2
Ishino et al. RTL4, a retrovirus-derived gene implicated in autism spectrum disorder, is a microglial gene that responds to noradrenaline in the postnatal brain
Katayama et al. Slitrk2 deficiency causes hyperactivity with altered vestibular function and serotonergic dysregulation
US12059433B2 (en) Treatment for autistic spectrum disorder (ASD) and relevant symptoms
Jia et al. Gm527 deficiency in dentate gyrus improves memory through upregulating dopamine D1 receptor pathway
Medrano et al. Mutant screen reveals the Piccolo's control over depression and brain-gonad crosstalk
US20200215204A1 (en) Early-onset parkinson's disease model: (d331y) pla2g6 knockin model, platform and method for drug screening, and kit of detection
Baum The Schizophrenia-Associated Gene, CSMD1, Encodes a Brain-Specific Complement Inhibitor
Fujino et al. Generation and mutational analysis of a transgenic murine model of the human MAF mutation
Samsom Cognitive phenotype in PICK1 and MIR137 point-mutation candidate models for schizophrenia
Kim et al. Bazedoxifene rescues sexually dimorphic autistic-like abnormalities in mice carrying a biallelic MDGA1 mutation
Wei et al. GPR158 in pyramidal neurons mediates social novelty behavior via modulating synaptic transmission in mice
Telenson A novel, rapidly progressive ataxia due to a spontaneous Myo5a mutation in mice impairs transport proteins and alters mitochondria